COVID-19 vaccine (Beijing Aimei Biological Vaccine Technology/Zhejiang Vbiosci Biotechnology)

N/A

Report date: 2025/01/26 19:30:11

Base Information

Drug NameCOVID-19 vaccine (Beijing Aimei Biological Vaccine Technology/Zhejiang Vbiosci Biotechnology)
Drug Alias NameSARS-CoV-2 vaccine(Beijing Aimei Biological Vaccine Technology/Zhejiang Vbiosci Biotechnology)protein subunit vaccine(Beijing Aimei Biological Vaccine Technology/Zhejiang Vbiosci Biotechnology)protein subunit vaccine (Beijing Aimei Biological Vaccine Technology/Zhejiang Vbiosci Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAim Vaccine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Dingzhi Biological Products Co LtdAim Vaccine Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A